TABLE 2.
Top 10 oral cancer drugs by total provincial expenditure for 2006–2007 (per capita spending on each drug in brackets)
| BC | AB | SK | ON | NS | NL | |
|---|---|---|---|---|---|---|
| 1 | Imatinib (Gleevec) $9,758,620 ($2.37) |
Leuprolide Gel $9,624,705 ($2.93) |
LHRH Analogs $3,226,730 ($3.33) |
Imatinib (Gleevec) $19,124,044 ($1.57) |
Goserelin (Zoladex) $1,554,624 ($1.70) |
Imatinib (Gleevec) $587,594 ($1.16) |
| 2 | Goserelin (Zoladex) $7,047,846 ($1.71) |
Imatinib (Gleevec) $6,623,894 ($2.01) |
Imatinib (Gleevec) $2,113,799 ($2.18) |
Anastrozole (Arimidex) $10,268,736 ($0.84) |
Leuprolide $1,035,401 ($1.13) |
Bicalutamide $214,669 ($0.42) |
| 3 | Leuprolide $5,599,655 ($1.36) |
Temozolomide (Temodal) $2,035,920 ($0.62) |
Filgrastim (G-CSF-Neupogen) $1,350,677 ($1.40) |
Bicalutamide $8,923,072 ($0.73) |
Imatinib (Gleevec) $804,872 ($0.88) |
Erlotinib (Tarceva) $91,642 ($0.18) |
| 4 | Anastrazole (Armidex) $3,243,415 ($0.79) |
Capecitabine (Xeloda) $1,708,605 ($0.52) |
Temozolomide (Temodal) $562,519 ($0.58) |
Letrozole (Femara) $5,721,234 ($0.47) |
Anastrozole (Arimidex) $706,940 ($0.77) |
Anastrozole (Arimidex) $88,370 ($0.17) |
| 5 | Octreotide (Sandostatin) $3,182,578 ($0.77) |
Anastrozole (Arimidex) $1,587,286 ($0.48) |
Octreotide (Sandostatin) $536,519 ($0.55) |
Temozolomide (Temodal) $5,685,141 ($0.47) |
Biclutamide $610,836 ($0.67) |
Capecitabine (Xeloda) $73,568 ($0.15) |
| 6 | Letrozole (Femara) $2,594,166 ($0.63) |
Letrozole (Femara) $1,066,913 ($0.32) |
Anastrozole (Arimidex) $516,696 ($0.53) |
Capecitabine (Xeloda) $4,294,417 ($0.35) |
Letrozole (Femara) $330,487 ($0.36) |
Letrozole (Femara) $64,807 ($0.13) |
| 7 | Temozolomide (Temodal) $2,554,144 ($0.62) |
Thalidomide $991,811 ($0.30) |
Capecitabine (Xeloda) $427,256 ($0.44) |
Methotrexate $2,332,915 ($0.19) |
Temozolomide (Temodal) $290,825 ($0.32) |
Tamoxifen $33,530 ($0.07) |
| 8 | Capecitabine (Xeloda)) $2,554,144 ($0.62) |
Interferon $837,077 ($0.25) |
Interferon $212,617 ($0.22) |
Erlotinib (Tarceva) $2,311,408 ($0.19) |
Capecitabine (Xeloda) $250,552 ($0.27) |
Hydroxy-carbamide $30,794 ($0.06) |
| 9 | Exemestane (Aromasin) $1,287,568 ($0.31) |
Erlotinib (Tarceva) $750,113 ($0.23) |
Letrozole (Femara) $199,950 ($0.21) |
Exemestane (Aromasin) $1,566,691 ($0.13) |
Buserelin $182,180 ($0.20) |
Megestrol (Megace) $19,461 ($0.04) |
| 10 | Buserelin $1,270,427 ($0.31) |
Fludarabine $571,044 ($0.17) |
Ondansetron/Granisetron $180,651 ($0.19) |
Megestrol (Megace) $1,490,249 ($0.12) |
Methotrexate $180,816 ($0.20) |
Exemestane (Aromasin) $18,009 ($0.04) |